Sensitivity to vaccines, therapeutic antibodies, and viral entry inhibitors and advances to counter the SARS-CoV-2 Omicron variant
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and
mutating into newer variants over time, which gain higher transmissibility, disease severity …
mutating into newer variants over time, which gain higher transmissibility, disease severity …
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study
Background Up to the end of January, 2022, South Africa has had four recognisable COVID-
19 pandemic waves, each predominantly dominated by one variant of concern: the ancestral …
19 pandemic waves, each predominantly dominated by one variant of concern: the ancestral …
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral …
Background In late 2021, the SARS-CoV-2 Omicron (B. 1.1. 529) variant of concern (VoC)
was reported with many mutations in the viral spike protein that were predicted to enhance …
was reported with many mutations in the viral spike protein that were predicted to enhance …
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
Summary Background SARS-CoV-2 Omicron variant is rampantly spreading across the
globe. We assessed the pathogenicity and immune response generated by BA. 1.1 sub …
globe. We assessed the pathogenicity and immune response generated by BA. 1.1 sub …
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
Despite being more transmissible, the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Omicron variant only causes milder diseases in laboratory animals, often …
(SARS-CoV-2) Omicron variant only causes milder diseases in laboratory animals, often …
[HTML][HTML] НОВЫЙ ШТАММ SARS-COV-2 ОМИКРОН-КЛИНИКА, ЛЕЧЕНИЕ, ПРОФИЛАКТИКА (ОБЗОР ЛИТЕРАТУРЫ)
ВИ Вечорко, ОВ Аверков, АА Зимин - … терапия и профилактика, 2022 - cyberleninka.ru
Несмотря на снижение уровня заболеваемости, на сегодняшний день проблема новой
коронавирусной инфекции (COVID-19, COronaVIrus Disease 2019) в глобальном …
коронавирусной инфекции (COVID-19, COronaVIrus Disease 2019) в глобальном …
Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model
Understanding the host pathways that define susceptibility to Severe-acute-respiratory-
syndrome-coronavirus-2 (SARS-CoV-2) infection and disease are essential for the design of …
syndrome-coronavirus-2 (SARS-CoV-2) infection and disease are essential for the design of …
Assessment of the biological impact of SARS-CoV-2 genetic variation using an authentic virus neutralisation assay with convalescent plasma, vaccinee sera, and …
In the summer of 2020, it became clear that the genetic composition of SARS-CoV-2 was
changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at …
changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at …
Booster vaccination with Ad26. COV2. S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA. 2
Since the original outbreak of the SARS-CoV-2 virus, several rapidly spreading SARS-CoV-
2 variants of concern (VOC) have emerged. Here, we show that a single dose of Ad26 …
2 variants of concern (VOC) have emerged. Here, we show that a single dose of Ad26 …